RESCUE MEDICATION USE REDUCTION WITH BENRALIZUMAB FOR PATIENTS WITH SEVERE, UNCONTROLLED EOSINOPHILIC ASTHMA

被引：1
|
作者：
O'Quinn, S.
Xu, X.
Hirsch, I.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2018年 / 121卷 / 05期
关键词：
D O I：
10.1016/j.anai.2018.09.057
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
D200
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [21] Effect of benralizumab on the immune response in patients with severe eosinophilic asthma
    Sematonyte, J.
    Bajoriuniene, I
    Sitkauskiene, B.
    ALLERGY, 2019, 74 : 364 - 364
  • [22] BENRALIZUMAB IMPROVES RESPIRATORY RESISTANCE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Badal, T.
    Cottee, A.
    Seccombe, L.
    Reed, N.
    Farah, C.
    RESPIROLOGY, 2020, 25 : 210 - 210
  • [23] ECONOMIC EVALUATION OF BENRALIZUMAB AS ADD-ON MAINTENANCE TREATMENT OF ADULT PATIENTS IN MEXICO WITH UNCONTROLLED SEVERE EOSINOPHILIC ASTHMA
    Buritica, M. P.
    Carmona Marin, M.
    Barriga, V
    Guzman, J.
    Carlos, F.
    VALUE IN HEALTH, 2020, 23 : S352 - S352
  • [24] Eosinophil depletion with benralizumab is associated with attenuated mannitol airway hyperresponsiveness in severe uncontrolled eosinophilic asthma
    Chan, Rory
    Kuo, Chris RuiWen
    Jabbal, Sunny
    Lipworth, Brian J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (03) : 700 - +
  • [25] OUTCOMES WITH MEPOLIZUMAB AND BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Elsey, L.
    Hince, K.
    Aspin, P.
    Pantin, C. T.
    Allen, D.
    Niven, R.
    Fowler, S. J.
    Tavernier, G.
    THORAX, 2021, 76 : A142 - A142
  • [26] REAL-LIFE EXPERIENCE OF BENRALIZUMAB IN PATIENTS WITH SEVERE UNCONTROLLED EOSINOPHILIC ASTHMA OVER 96-WEEK PERIOD
    Guadarrama, A.
    Singh, H.
    Diaz, J.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S36 - S36
  • [27] Clinical Efficacy of Benralizumab in Patients With Severe, Uncontrolled Eosinophilic Asthma and Nasal Polyposis: Pooled Analysis of the SIROCCO and CALIMA Trials
    Maspero, Jorge
    Harrison, Tim
    Werkstrom, Viktoria
    Wu, Yanping
    Gopalan, Gokul
    Zangrilli, James
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB12 - AB12
  • [28] Personalized Approach of Severe Eosinophilic Asthma Patients Treated with Mepolizumab and Benralizumab
    Bergantini, Laura
    d'Alessandro, Miriana
    Cameli, Paolo
    Bianchi, Francesco
    Sestini, Piersante
    Bargagli, Elena
    Refini, Rosa Metella
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2020, 181 (10) : 746 - 753
  • [29] COMPREHENSIVE RESPONSE TO BENRALIZUMAB BY PATIENTS WITH NASAL POLYPOSIS AND SEVERE, EOSINOPHILIC ASTHMA
    Kreindler, J.
    Chanez, P.
    Bourdin, A.
    Burden, A.
    Garcia Gil, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S29 - S29
  • [30] Relationship Between Benralizumab Exposure and Efficacy for Patients With Severe Eosinophilic Asthma
    Chia, Yen Lin
    Yan, Li
    Yu, Binbing
    Wang, Bing
    Barker, Peter
    Goldman, Mitchell
    Roskos, Lorin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (02) : 383 - 390
12345